New developments in antiretroviral drug therapy for HIV infection.
Johnson
V A
VA
University of Alabama, Birmingham.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000998:Antiviral Agents / Q000627:therapeutic use*; D016049:Didanosine / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D015696:Gene Products, tat / Q000037:antagonists & inhibitors; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D011480:Protease Inhibitors / Q000627:therapeutic use; D016047:Zalcitabine / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use; D054322:tat Gene Products, Human Immunodeficiency Virus
D000998:Antiviral Agents; D004338:Drug Combinations; D015696:Gene Products, tat; D011480:Protease Inhibitors; D054322:tat Gene Products, Human Immunodeficiency Virus; D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine